Drug-coated balloon for coronary artery blockages
Part of Heart & circulation clinical trials.
This trial studies whether a drug-coated balloon can treat certain coronary artery narrowings in adults with chronic (long-term) coronary disease. It may help prevent re-narrowing after the procedure for people whose tests show the blockage is significant and needs treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older
- Have chronic coronary artery disease and be considered suitable for a stent/PCI procedure
- Have at least one significant new (de-novo) coronary blockage: more than 50% narrowed with flow test results (FFR or iFR within the trial’s limits) and an IVUS plan for a long drug-eluting stent (30 mm or longer)
- Not be having treatment for an acute coronary problem (like a heart attack or unstable chest pain)
- The blockage location must not be at the left main or certain artery openings (left circumflex or right coronary ostium)
- You must be able to safely receive adenosine (no key adenosine contraindications), and you are not pregnant/breast-feeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares a drug-coated balloon (medicated balloon) to a drug-eluting stent (medicated mesh tube) for treating new blockages in heart arteries. It is designed for patients with a high risk of bleeding who have completed a short course of anti-clotting medication and have been event-free for at least one year.
This trial is testing a special balloon coated with medication to treat newly formed blockages in the heart's arteries. The medication may help keep the artery open after the balloon opens it during a standard procedure.
This trial tests a special balloon coated with medicine to open blocked coronary arteries (blood vessels to the heart). The procedure uses ultrasound and imaging guidance to help doctors decide whether to use the drug-coated balloon alone, which may reduce the need for stents and future complications.
This trial tests a special balloon coated with a drug (sirolimus) to treat blockages in small heart arteries. If the balloon is successful, it may help keep the artery open without needing a permanent stent.
This trial tests whether a drug-coated balloon is a good treatment option for people who have blockages in two or more heart arteries. It aims to see if this approach can safely open blocked arteries without a permanent stent.
This trial tests how the way a drug-coated balloon is used during a heart procedure affects outcomes for people with stable heart disease or unstable angina. It may help doctors find the best technique to keep arteries open.
Hear when a new Chronic Coronary Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.